Squarepoint’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,563
| Closed | -$8.92K | – | 2723 |
|
|
2024
Q4 | $8.92K | Buy |
+16,563
| New | +$8.92K | ﹤0.01% | 2726 |
|
|
2022
Q2 | – | Sell |
-10,800
| Closed | -$22K | – | 2074 |
|
|
2022
Q1 | $22K | Sell |
10,800
-31,589
| -75% | -$64.3K | ﹤0.01% | 2139 |
|
|
2021
Q4 | $159K | Buy |
42,389
+10,508
| +33% | +$39.4K | ﹤0.01% | 2181 |
|
|
2021
Q3 | $165K | Buy |
31,881
+17,884
| +128% | +$92.6K | ﹤0.01% | 1896 |
|
|
2021
Q2 | $60K | Sell |
13,997
-24,216
| -63% | -$104K | ﹤0.01% | 2488 |
|
|
2021
Q1 | $203K | Sell |
38,213
-17,487
| -31% | -$92.9K | ﹤0.01% | 2153 |
|
|
2020
Q4 | $300K | Sell |
55,700
-7,585
| -12% | -$40.9K | ﹤0.01% | 1855 |
|
|
2020
Q3 | $505K | Buy |
+63,285
| New | +$505K | 0.01% | 1342 |
|
|
2020
Q2 | – | Sell |
-12,552
| Closed | -$34K | – | 2111 |
|
|
2020
Q1 | $34K | Buy |
+12,552
| New | +$34K | ﹤0.01% | 1740 |
|
|
2019
Q1 | – | Sell |
-108,100
| Closed | -$622K | – | 2057 |
|
|
2018
Q4 | $622K | Buy |
+108,100
| New | +$622K | 0.01% | 1129 |
|
|
2018
Q3 | – | Sell |
-50,200
| Closed | -$596K | – | 1944 |
|
|
2018
Q2 | $596K | Buy |
50,200
+8,700
| +21% | +$103K | 0.01% | 1103 |
|
|
2018
Q1 | $466K | Buy |
41,500
+15,300
| +58% | +$172K | 0.01% | 1111 |
|
|
2017
Q4 | $175K | Buy |
26,200
+8,646
| +49% | +$57.8K | ﹤0.01% | 1823 |
|
|
2017
Q3 | $144K | Buy |
+17,554
| New | +$144K | ﹤0.01% | 1444 |
|